![Suk Ping Lam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Suk Ping Lam
Keine laufenden Positionen mehr
Karriereverlauf von Suk Ping Lam
Ehemalige bekannte Positionen von Suk Ping Lam
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Direktor/Vorstandsmitglied | 20.05.2016 | 22.01.2020 |
Independent Dir/Board Member | 20.05.2016 | 22.01.2020 | |
GOLDSTONE INVESTMENT GROUP LIMITED | Direktor/Vorstandsmitglied | 30.06.2011 | 20.10.2011 |
Independent Dir/Board Member | 30.06.2011 | 20.10.2011 | |
CHINA RUYI HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 07.04.2008 | 27.04.2011 |
OCI INTERNATIONAL HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 01.06.2011 | 06.07.2017 |
Finanzdirektor/CFO | 06.07.2017 | - |
Ausbildung von Suk Ping Lam
The University of Hull | Masters Business Admin |
Hong Kong Metropolitan University | Graduate Degree |
Statistik
International
Hong Kong | 5 |
China | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Masters Business Admin | 1 |
Sektoral
Consumer Services | 3 |
Finance | 3 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
CHINA RUYI HOLDINGS LIMITED | Miscellaneous |
GOLDSTONE INVESTMENT GROUP LIMITED | Finance |
OCI INTERNATIONAL HOLDINGS LIMITED | Finance |
Private Unternehmen | 1 |
---|---|
Mingyuan Medicare Development Co. Ltd.
![]() Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
- Börse
- Insiders
- Suk Ping Lam
- Erfahrung